# FDA Inspection 1032319 - LEO Pharma Ireland - November 03, 2017

Source: https://www.keypedia.com/records/fda_inspections/leo-pharma-ireland/1a92ceaf-42dc-4c0c-8c4b-5e268a0677ab
Source feed: FDA_Inspections

> FDA Inspection 1032319 for LEO Pharma Ireland on November 03, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1032319
- Company Name: LEO Pharma Ireland
- Inspection Date: 2017-11-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1172983 - 2022-06-24](https://www.keypedia.com/records/fda_inspections/leo-pharma-ireland/e59e55dd-779a-4596-8c8a-44a8502783d9)
- [FDA Inspection 877763 - 2014-03-14](https://www.keypedia.com/records/fda_inspections/leo-pharma-ireland/50f91ae9-8bd9-4186-a012-6a48ee2751fe)
- [FDA Inspection 745395 - 2011-09-09](https://www.keypedia.com/records/fda_inspections/leo-pharma-ireland/954b5f6e-f46a-459e-8fb6-ee4aaf7a8974)
- [FDA Inspection 556572 - 2008-12-08](https://www.keypedia.com/records/fda_inspections/leo-pharma-ireland/bed7e491-1626-49c3-8788-58dea7f5e0bc)

Company: https://www.keypedia.com/companies/leo-pharma-ireland/59203974-017b-455b-b585-13cd35d25ed9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c